Role of PI3K/Akt and MEK/ERK in Mediating Hypoxia-induced Expression of HIF-1alpha and VEGF in Laser-induced Rat Choroidal Neovascularization
Overview
Authors
Affiliations
Purpose: The transcription factor hypoxia-inducible factor (HIF)-1 plays a central physiological role in oxygen and energy homeostasis and is activated during hypoxia by stabilization of the subunit HIF-1alpha. Hypoxia plays an important role in the development of choroidal neovascularization (CNV). Expression of HIF-1alpha has been demonstrated in CNV. Vascular endothelial growth factor (VEGF) is one of the most well-characterized angiogenic factors in CNV, which is under the regulation of HIF-1. The aim of the present study was to explore the upstream signaling pathways involved in regulating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat CNV.
Methods: A well-established rat model of CNV and cultured human retinal pigment epithelium (hRPE) was used to investigate the role of PI3K/Akt and MEK/ERK pathways in regulating HIF-1alpha and VEGF expression in CNV in rat and hRPE under hypoxia by immunohistochemistry, Western blot analysis, real-time PCR, and ELISA.
Results: pAkt, pERK, HIF-1alpha, and VEGF were upregulated in vivo and in vitro. PI3K inhibitor (Ly294002) significantly decreased pAkt activity and HIF-1alpha and VEGF expression in vivo and in vitro, whereas MEK inhibitor (PD98059) reduced ERK phosphorylation and the expression of VEGF but had no effect on HIF-1alpha. LY294002 and PD98059 severely inhibited the formation of CNV.
Conclusions: The PI3K/Akt pathway was required for hypoxia-induced expression of HIF-1alpha and VEGF, whereas the MEK/ERK pathway was required only for VEGF in laser-induced rat CNV.
Xiao J, Luo W, Mani A, Barba H, Solanki A, Droho S Int J Mol Sci. 2024; 25(21).
PMID: 39518910 PMC: 11545389. DOI: 10.3390/ijms252111357.
Nishikiori N, Sato T, Ogawa T, Higashide M, Umetsu A, Suzuki S Bioengineering (Basel). 2024; 11(6).
PMID: 38927817 PMC: 11201039. DOI: 10.3390/bioengineering11060581.
Liang Y, Kong L, Zhang Y, Zhang Y, Shi M, Huang J Theranostics. 2024; 14(4):1500-1516.
PMID: 38389841 PMC: 10879880. DOI: 10.7150/thno.92943.
Nakai A, Lee D, Shoda C, Negishi K, Nakashizuka H, Yamagami S J Ophthalmol. 2024; 2023:6617981.
PMID: 38187496 PMC: 10771337. DOI: 10.1155/2023/6617981.
Shen Y, Xu M, Ren L, Li X, Han X, Cao X Sci Rep. 2023; 13(1):10439.
PMID: 37369771 PMC: 10300120. DOI: 10.1038/s41598-023-37619-7.